Search research articles
Contact Us
Filters
Showing results (421-430 of 538) with videos related to
Page
of 54
Sort By:
Annals of Internal Medicine
|
June 20, 2013
Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial
Kenneth W Mahaffey, Daniel Wojdyla, Graeme J Hankey, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
December 29, 2018
Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Ben O'Brien, Peter S Burrage, Jennie Yee Ngai, et al.
Journal of the American Heart Association
|
March 5, 2015
Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial
Daniel E Singer, Anne S Hellkamp, Zhong Yuan, et al.
European Heart Journal
|
March 1, 2024
Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry
Mikhael F El-Chami, Christophe Garweg, Nicolas Clementy, et al.
Heart Rhythm
|
January 24, 2017
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial
Jonathan P Piccini, Kurt Stromberg, Kevin P Jackson, et al.
Circulation
|
February 21, 2014
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
Matthew W Sherwood, James D Douketis, Manesh R Patel, et al.
American Heart Journal
|
December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
American Heart Journal
|
October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study
Jonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
Page
of 54
Search research articles
Search
Showing results (421-430 of 538) with videos related to
Sort By:
Page
of 54
Annals of Internal Medicine
|
June 20, 2013
Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial
Kenneth W Mahaffey, Daniel Wojdyla, Graeme J Hankey, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
December 29, 2018
Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Ben O'Brien, Peter S Burrage, Jennie Yee Ngai, et al.
Journal of the American Heart Association
|
March 5, 2015
Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial
Daniel E Singer, Anne S Hellkamp, Zhong Yuan, et al.
European Heart Journal
|
March 1, 2024
Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry
Mikhael F El-Chami, Christophe Garweg, Nicolas Clementy, et al.
Heart Rhythm
|
January 24, 2017
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial
Jonathan P Piccini, Kurt Stromberg, Kevin P Jackson, et al.
Circulation
|
February 21, 2014
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
Matthew W Sherwood, James D Douketis, Manesh R Patel, et al.
American Heart Journal
|
December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
American Heart Journal
|
October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study
Jonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
Page
of 54